Mercury Biopharmaceutical Revenue

Mercury Biopharmaceutical had revenue of 4.72M TWD in the half year ending June 30, 2024. This brings the company's revenue in the last twelve months to 5.75M, up 114.55% year-over-year. In the year 2023, Mercury Biopharmaceutical had annual revenue of 1.03M, down -61.46%.

Revenue (ttm)

5.75M

Revenue Growth

+114.55%

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

n/a

Market Cap

6.57B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.03M	-1.65M	-61.46%
Dec 31, 2022	2.68M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition